InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Rosenblum Mark J, Chief Financial Officer. Officer active across 1 company, notably Salarius Pharmaceuticals, Inc.. In total, 12 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €32k. Activity tracked since 3 May 2021. The latest transaction was filed on 13 February 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
6,432 shares0Common StockSEC:0001615219-23-000025:0
8,000 shares0Common StockSEC:0001615219-23-000004:0
1,488 shares@ US$1.7343.3% of flowCommon StockSEC:0001615219-22-000153:0
7,314 shares@ US$1.73416.1% of flowCommon StockSEC:0001615219-22-000143:0
7,314 shares@ US$1.73416.1% of flowCommon StockSEC:0001615219-22-000141:0
28,000 shares@ US$0.189.0% of flowCommon StockSEC:0001615219-22-000085:0
Ideal exit: 25 Feb 2023 (T+270)
10,000 shares@ US$0.18633.4% of flowCommon StockSEC:0001615219-22-000067:0
76,246 shares@ US$0.39151.7% of flowCommon StockSEC:0001615219-22-000019:0
Ideal exit: 28 Nov 2022 (T+270)
7,787 shares@ US$0.71851.8% of flowCommon StockSEC:0001615219-21-000095
7,787 shares@ US$0.7189.3% of flowCommon StockSEC:0001615219-21-000095:0
9,563 shares@ US$0.5678.7% of flowCommon StockSEC:0001615219-21-000042:0
9,563 shares@ US$0.5678.7% of flowCommon StockSEC:0001615219-21-000042
12 of 12 declarations
About Rosenblum Mark J
Mark J. Rosenblum is Executive Vice President and Chief Financial Officer at Salarius Pharmaceuticals, Inc. He oversees the financial operations of the company, ensuring effective resource management and contributing to financial strategy. His role is essential for the financial health of the organization.
